Applications Published 16 August 2000
Published: 26-Feb-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Treatment of schizophrenia with ampakinen and neuroleptics
Cortex Pharmaceuticals 1026950*Non-invasive real time diagnosis of migraine
Inta Medica 1026989*Adminstration of active agents, including 5-HT receptor agonists, and antagonists, to treat premature ejaculation
Vivus 1027011*Impantable system with drug-eluting cells for on-demand local drug delivery
Medtronic 1027014*Controlled release of pharmaceuticals in the anterior chamber of the eye
Galin, Miles; Salamone, Joseph; Israel, Stanley 1027015*Methods and pharmaceutical compsns for the closure of retinal breaks
The Regents of the University of California 1027016*Therapeutic method
Aukland Uniservices Ltd 1027027*Ester-terminated polyamide gels
Union Camp International 1027032*High efficiency encapsulation of charged therapeutic agents in lipid vesicles
Inex Pharmaceuticals Corp 1027033*Marker for intestinal diagnosis and intestinal therapy
Insitut fur Physikalische Hochtechnologie 1027034*Preparation of a lipid blend and a phospholipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
DuPont Pharmaceuticals 1027035*Taste-masked formulations
Elan Corp 1027036*Pharnaceutical preparation comprising clodronate as active ingredient and silicised microcrystalline cellulose and excipient
Leiras 1027037*Taste-masked pharmaceutical compsns
FMC Corp 1027038*Effervescent granules
Farmo-Nat 1027039*Methods for modulating macrophage proliferation using polyamine analogues
The Regents of the University of California 1027040*Novel cyanoaziridines for treating cancer
The Arizona Board of Regents, on behalf of the University of Arizona 1027041*Inhibitors of farnesyl protein transferase
Bristol-Myers Squibb 1027042*Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
Bristol-Myers Squibb 1027043*Methods of treating and preventing endometriosis with phytoestrogens
Wake Forest University 1027044*Methods and compsns for regulation of 5-alpha reductase activity
Arch Development 1027045*Antagonists of gonadotropin-releasing hormone
Merck 1027046*Eprosartan arginyl charge-neutralisation-complex and a process for its production and formulation
SmithKline Beecham 1027047*Selective cyclooxygenase-2 inhibitors against premature labour
GD Searle 1027048*Intranasal formulation containing scopolamine and method of treating motion sickness
Nastech Pharmaceuticals 1027049*Antithrombitic agents
Eli Lilly 1027051*Novel combination
AstraZeneca 1027053*Local administration of phosphodiesterase inhibitors for the treatment of erectiole dysfunction
Vivus 1027054*Alpha-ketoamide multicatalytic protease inhibitors
Cephalon 1027056*Tretamentof female sexual dysfunction
Asivi 1027057*Disacharide derivatives for treating hyperglycaemia
Sudzucker Aktiengesellschaft Mannhein/Ochsenfurt 1027058*Enhancement of morphogen activity
Creative Biomolecules 1027059*Use of macrolides for the treatment of cancer and macular degenration
Abbott Laboratories 1027060*Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
Galenica Pharmaceuticals 1027061*Mannose receptor bearing cell line and antigen compsn
The Austin Research Institute 1027063*Method for removing undesirabvle toxic alkoloids from plants or vegetable preparations
Emil Flaschmann 1027064*Method for destroting retinal pigment epithelial cells
Bausch & Lomb 1027065*Soluble MHC complexes and methods of use thereof
Sunol Molecular Corp 1027066*Use of substances havign oxytocin activity for the preparation of medicaments for the treatment o fafective pain syndrome
EntreTech Medical 1027067*Oromucolsal cytokine compsns and uses thereof
Pharma Pacific 1027068*Compsns and methods for treating lysosomal storage disease
Genzyme Corp 1027069*Conjugate heat shcok protein-binding peptides
Sloan-Kettering Institute for Cancer Research 1027070*Encapsulated immunomodulators useful as vaccine adjuvants
Cistron Biotechnology 1027071*Controlled release compsns comprising gellan gum gels
Monstanto 1027072*Enhanced effects for hapten conjugated therapeutics
Sangstat Medical Corp 1027073*Compsns and methods for delivery of genetic material
American Home Products 1027074*Gene therapy for stimulation of angiogenesis
Merck 1027075*Use of vectors such as adenoviruses and/or adeno associated viruses and/or Herpes simplex viruses and/or plasmids as a vehicle for genetic information enabling mammal cells to produce agents for the treatment of bone pathologies
University of Pittsburgh of the Commonwealth System of Higher Education 1027076*Magnetic resonance imaging agents for the delivery of therapeutic agents
California Institute of Technology 1027077*Immunisation against (Streptococcus pneumoniae)using conjugated and unconjugated pneumococcal polysaccharide vaccines
Merck 1027078*Enhancement of delivery of radioimaging and radioprotective agents
Platt, David 1027079*Method of detection of fibrin clots
The Australian National University 1027080*Styryl sulphone anticancer agents
Temple University of the Commonwealth System of Higher Education 1027330*Method for producing aryl thiols by hydrogenating diarylsulphides
Bayer 0127331*Novel lactam metalloprotease inhibitors
DuPont Pharmaceuticals 1027332*Thrombin inhibitors
Merck 1027333*Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents
Cerebrus Pharmaceuticals 1027335*Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
Neurosearch 1027336*Integrin receptor anatgonists
SmithKlineBeecham 1027337*New carboxylix acid derivatives carrying amido side-chains; production and use as endothelin receptor antagonists
BASF 1027338*Method and reagents for N-alkylating ureides
Taro Pharmaceutical 1027339*High char yield benzoxazines
Edison Polymer Innovation 1027341*Cyclopentene derivatives useful as antagonists of the motilin receptor
Ortho-McNeil Pharmaceutical 1027342*Process for the preparation of hydroxy substituted butyrolactones
Michigan State University 1027343*Pharmaceutical compounds isolated from Aristolochia taliscana
Proteome Sciences 1027344*Synthetic methods for polyphenols
Mars Inc 1027345*Photochromically derivatives of carbocyclically fused naphthopyrans
Transitions 1027346*Tatrahydrofuran phosphate and hydroxy esters as prodrugs for the corresponding antifungal agents
Schering 1027349*Aminomethyl-benzo a]quinolizidine derivatives, preparation and therapeutic applications for neurodegenerative diseases
Pierre Fabre Medicament 1027350*Phenanthroline derivatives
Fibrogen; Zeneca 1027351*Carbapenem antibacterial compounds, compsns and methods of treatment
Merck 1027352*Phthalocyanine analogues
The Secretary of State for Defence, Defence Evaluation and Research Agency 1027354*Antitumour uridine analogues
The Government of the United States of America, as represented by the Secreatry of State of the Department of Health and Human Services 1027365*Process for the production of highyl viral safe components for forming fibrin glue from a pool of human plasma
Haemacure 1027371*
